As of Sep 22
| +0.67 / +1.78%|
The 6 analysts offering 12-month price forecasts for Emergent BioSolutions Inc have a median target of 40.50, with a high estimate of 50.00 and a low estimate of 36.00. The median estimate represents a +5.63% increase from the last price of 38.34.
The current consensus among 6 polled investment analysts is to Buy stock in Emergent BioSolutions Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.